Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of SIRT1 in fatty liver diseases
Ren‐Bo Ding, Jiaolin Bao, Chu‐Xia Deng
International Journal of Biological Sciences (2017) Vol. 13, Iss. 7, pp. 852-867
Open Access | Times Cited: 295

Showing 1-25 of 295 citing articles:

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease
Mario Masarone, Valerio Rosato, Marcello Dallio, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, pp. 1-14
Open Access | Times Cited: 559
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Hannah Chew, Victoria Solomon, Alfred N. Fonteh
Frontiers in Physiology (2020) Vol. 11
Open Access | Times Cited: 263
NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Biomolecules (2022) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 244
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Oriol Juanola, Sebastián Martínez‐López, Rubén Francés, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 10, pp. 5227-5227
Open Access | Times Cited: 194
Association of metabolic dysfunction-associated fatty liver disease with kidney disease
Ting-Yao Wang, Rui-Fang Wang, Zhi-Ying Bu, et al.
Nature Reviews Nephrology (2022) Vol. 18, Iss. 4, pp. 259-268
Open Access | Times Cited: 141
The Interplay between Insulin Resistance, Inflammation, Oxidative Stress, Base Excision Repair and Metabolic Syndrome in Nonalcoholic Fatty Liver Disease
Sylwia Ziółkowska, Agata Binienda, Maciej Jabłkowski, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11128-11128
Open Access | Times Cited: 116
Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 103
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
Mette Yde Hochreuter, Morten Dall, Jonas T. Treebak, et al.
Molecular Metabolism (2022) Vol. 65, pp. 101581-101581
Open Access | Times Cited: 76
Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction
Karli R. LeFort, Wiramon Rungratanawanich, Byoung‐Joon Song
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 31
Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond
Allison Soto, Colby Spongberg, Alessandro Martinino, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 397-397
Open Access | Times Cited: 21
Activation of SIRT1 by SRT1720 Alleviates Dyslipidemia, Improves Insulin Sensitivity and Exhibits Liver-Protective Effects in Diabetic Rats on a High-Fat Diet: New Insights into the SIRT1/Nrf2/NFκB Signaling Pathway
Elsayed A. Elmorsy, Hossam A. Elsisi, Abdullah S. Alkhamiss, et al.
European Journal of Pharmaceutical Sciences (2025) Vol. 206, pp. 107002-107002
Open Access | Times Cited: 2
Brain SIRT1 Mediates Metabolic Homeostasis and Neuroprotection
Jing Xu, Charlie W. Jackson, Nathalie Khoury, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 133
Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway
Charng-Cherng Chyau, Hsueh‐Fang Wang, Wenjuan Zhang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 1, pp. 360-360
Open Access | Times Cited: 124
In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal
Pierre‐Antoine Soret, Julie Magusto, Chantal Housset, et al.
Journal of Clinical Medicine (2020) Vol. 10, Iss. 1, pp. 36-36
Open Access | Times Cited: 95
Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation
Annalisa Roberti, Agustín F. Fernández, Mario F. Fraga
Molecular Metabolism (2021) Vol. 45, pp. 101165-101165
Open Access | Times Cited: 89
Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism
Alexandra Collin de l’Hortet, Kazuki Takeishi, Jorge Guzman‐Lepe, et al.
Cell Metabolism (2019) Vol. 30, Iss. 2, pp. 385-401.e9
Open Access | Times Cited: 86
The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease
Ali Bayoumi, Henning Grønbæk, Jacob George, et al.
Trends in Genetics (2020) Vol. 36, Iss. 6, pp. 429-441
Closed Access | Times Cited: 82
Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe−/−mice: role of SIRT1
Yi Qiao Hua, Yi Zeng, Jin Xu, et al.
Phytomedicine (2020) Vol. 81, pp. 153412-153412
Closed Access | Times Cited: 79
DSS-induced colitis is associated with adipose tissue dysfunction and disrupted hepatic lipid metabolism leading to hepatosteatosis and dyslipidemia in mice
Jeonghyeon Kwon, Chungho Lee, Sungbaek Heo, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 78
Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Raquel Cano, José L. Pérez, Lissé Angarita, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4807-4807
Open Access | Times Cited: 75
LARP7 ameliorates cellular senescence and aging by allosterically enhancing SIRT1 deacetylase activity
Pengyi Yan, Zixuan Li, Junhao Xiong, et al.
Cell Reports (2021) Vol. 37, Iss. 8, pp. 110038-110038
Open Access | Times Cited: 67
SGLT2 Inhibitors as Calorie Restriction Mimetics: Insights on Longevity Pathways and Age-Related Diseases
Caroline Wei Shan Hoong, Marvin Wei Jie Chua
Endocrinology (2021) Vol. 162, Iss. 8
Open Access | Times Cited: 60
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 45
Pharmacological Effects and Molecular Protective Mechanisms of Astragalus Polysaccharides on Nonalcoholic Fatty Liver Disease
Jing Zhang, Quansheng Feng
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Sadeesh K. Ramakrishnan
Comprehensive physiology (2022), pp. 3167-3192
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top